Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene-expression profiles of ascites-cytology-positive ovarian cancer


ABSTRACT: Ovarian cancer often progresses by disseminating to the peritoneal cavity, but how the tumor cells evade host immunity during this process is poorly understood. Programmed cell death 1 ligand 1 (PD-L1) is known to suppress immune system and to be an unfavorable prognostic factor in ovarian cancer. The purpose of this study was to elucidate the function of PD-L1 in peritoneal dissemination. Positive cytology in ascites was a significant poor prognostic factor in ovarian cancer. Microarray profiles of cytology-positive cases showed significant correlations with Gene Ontology terms related to immune system process. Microarray and immunohistochemistry in human ovarian cancer revealed significant correlation between PD-L1 expression and positive cytology. PD-L1 expression on mouse ovarian cancer cells was induced upon encountering lymphocytes in the course of peritoneal spread in vivo and upon co-culturing with lymphocytes in vitro. Tumor cell lysis by CTLs was attenuated when PD-L1 was overexpressed and promoted when it was silenced. PD-L1 overexpression also inhibited gathering and degranulation of CTLs. In mouse ovarian cancer dissemination models, depleting PD-L1 expression on tumor cells resulted in inhibited tumor growth in the peritoneal cavity and prolonged survival. Restoring immune function by inhibiting immune-suppressive factors such as PD-L1 may be a promising therapeutic strategy for peritoneal dissemination. Genome-wide transcriptional changes in human ovarian cancer tissue from ascites-cytology-positive or -negative patients.

ORGANISM(S): Homo sapiens

SUBMITTER: Kaoru Abiko 

PROVIDER: E-GEOD-39204 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-07-10 | GSE39204 | GEO
2012-07-09 | E-GEOD-39205 | biostudies-arrayexpress
2012-07-10 | GSE39205 | GEO
2014-03-04 | E-GEOD-55512 | biostudies-arrayexpress
2014-03-04 | GSE55512 | GEO
| PRJNA170198 | ENA
2017-12-19 | GSE73064 | GEO
2024-05-29 | PXD019327 | Pride
2024-05-29 | PXD045647 | Pride
2024-04-24 | GSE241909 | GEO